Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications.

Human immunology - 1 Sept 2006

Romzova Marianna, Hohenadel Daniela, Kolostova Katarina, Pinterova Daniela, Fojtikova Marketa, Ruzickova Sarka, Dostal Ctibor, Bosak Vladimir, Rychlik Ivan, Cerna Marie

Abstract excerpt

Nuclear factor kappa B (NFkappaB) is an important transcription factor that together with its inhibitor (IkappaB) participates in the activation of genes involved in immune responses. We examined the CA repeat polymorphism of the NFKB1 gene (encoding for NFkappaB) and A/G point variation in the 3'UTR region of the nuclear factor kappa B inhibitor alpha (NFKBIA) gene (encoding for IkappaB) in Czech and German...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Capillaries

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Diabetic Nephropathies

Share to I-kappa B Kinase

Share to Kidney

Share to Lupus Erythematosus, Systemic

Share to NF-kappa B

Source

Identifiers

PMID: 17002901
DOI: 10.1016/j.humimm.2006.05.006

Genes

NFKBIA
NFKB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications.PMID 17002901Read ↗

NFkappaB polymorphisms and susceptibility to type 1 diabetes.Semantic proximity Read ↗

Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and their association with type 2 diabetes and impaired renal function.Semantic proximity Read ↗

HLA, NFKB1 and NFKBIA gene polymorphism profile in autoimmune diabetes mellitus patients.Semantic proximity Read ↗

NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases.Semantic proximity Read ↗

Nuclear factor NF-κB1 functional promoter polymorphism and its expression conferring the risk of Type 2 diabetes-associated dyslipidemia.Semantic proximity Read ↗

Characterization of a nuclear-factor-kappa B (NFkappaB) genetic marker in type 1 diabetes (T1DM) families.Semantic proximity Read ↗

Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.Semantic proximity Read ↗

Variant in the 3' region of the IkappaBalpha gene associated with insulin resistance in Hispanic Americans: The IRAS Family Study.Semantic proximity Read ↗

NFkappaB1 gene does not affect type 1 diabetes predisposition in a Spanish population.Semantic proximity Read ↗

Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations.Semantic proximity Read ↗

IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese.Semantic proximity Read ↗

Identification of NF-kappaB1 and NF-kappaBIAlpha polymorphisms using PCR-RFLP assay in a Turkish population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.